The synaptic connections that form between neurons during development remain plastic and able to adapt throughout the lifespan, enabling learning and memory. However, during aging and in particular in neurodegenerative diseases, synapses become dysfunctional and degenerate, contributing to dementia. In the case of Alzheimer's disease (AD), synapse loss is the strongest pathological correlate of cognitive decline, indicating that synaptic degeneration plays a central role in dementia. Over the past decade, strong evidence has emerged that oligomeric forms of amyloid beta, the protein that accumulates in senile plaques in the AD brain, contribute to degeneration of synaptic structure and function. More recent data indicate that pathological forms of tau protein, which accumulate in neurofibrillary tangles in the AD brain, also cause synaptic dysfunction and loss. In this review, we will present the case that soluble forms of both amyloid beta and tau protein act at the synapse to cause neural network dysfunction, and further that these two pathological proteins may act in concert to cause synaptic pathology. These data may have wide-ranging implications for the targeting of soluble pathological proteins in neurodegenerative diseases to prevent or reverse cognitive decline.
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Introduction
Alzheimer's disease (AD) is the most common cause of dementia in the elderly. It is a terrible burden for patients, their families, and caregivers, and it is also a potentially crippling public health problem for the entire world due to our aging population. The most significant risk factor for AD is age. Approximately 1 in 8 people over 65 is diagnosed with Alzheimer's and the risk of disease doubles every five years to over 40% of people over 80 diagnosed with the disease (Association, 2012). Pathologically, AD is characterized by atrophy of the hippocampus and neocortex resulting from neuron and synapse loss and the deposition of two proteinaceous lesions: senile plaques, composed primarily of the amyloid beta peptide (A␤) and neurofibrillary tangles (NFT) composed of hyperphosphorylated tau protein (Gomez-Isla et al., 2008) . Fig. 1 summarizes the pathological lesions observed in AD.
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cognitive decline (DeKosky and Scheff, 1990; Terry et al., 1991) . Synapse loss also exceeds the amount that would be predicted by the loss of connections from neurons that die in the brain (Arendt, 2009; Coleman and Yao, 2003) . This indicates that synaptic degeneration plays a central role in causing dementia. During development, the formation and pruning of synaptic connections is highly dynamic. Furthermore, the ability of synapses to change in response to neural activity is retained throughout adulthood. A widely held view is that this synaptic plasticity plays a key role in the ability to learn and to form new memories (Bourne and Harris, 2008; Caroni et al., 2012) . Loss of synapses is common to all neurodegenerative diseases. Since synapses are plastic, they have the potential to be restored, thus they are an attractive target for therapeutic intervention. As such, the cause of synapse dysfunction and loss in AD has been the focus of many studies over the past several years.
Altered A␤ production is strongly implicated in the initiation of AD by genetic mutations associated with rare familial cases and those cases associated with trisomy 21, which triplicates the precursor of A␤ (amyloid precursor protein) (Bertram and Tanzi, 2008) . Because of this strong evidence linking A␤ to AD pathogenesis, much of the work on synapse degeneration has focused on A␤, as will be summarized in Section 2. However, amyloid pathology does not correlate well with cognitive decline or synapse loss in AD, and
